Komplikasi Sindrom Stevens-Johnson (SSJ) dan Nekrolisis Epidermal Toksik (NET)
DOI:
https://doi.org/10.55175/cdk.v51i2.876Kata Kunci:
Komplikasi, nekrolisis epidermal toksik, sindrom Stevens-JohnsonAbstrak
Sindrom Stevens-Johnson (SSJ) dan nekrolisis epidermal toksik (NET) adalah reaksi mukokutaneus yang mengancam jiwa dengan keterlibatan kulit yang parah; banyak sistem organ internal ikut terpengaruh dengan komplikasi psikososial yang bermakna. Beberapa penelitian telah melaporkan komplikasi fisik dan psikososial yang signifikan. Penderita SSJ/NET memerlukan perawatan multidisiplin untuk menangani komplikasi psikologis dan penurunan kualitas hidup.
Unduhan
Referensi
Mockenhaupt M, Roujeau JCl. Epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis. Fitzpatrick’s dermatology. 9th. ed. McGraw Hill; 2019. p.767.
Carrasquillo OY. Santiago-V Marel, Cardona R. Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective descriptive study. Int J Dermatol. 2019;58(11):1293-9. DOI: 10.1111/ijd.14493.
Frantz R, Huang S, Are A, Motaparthi K. Stevens–Johnson syndrome and toxic epidermal necrolysis: A review of diagnosis and management. Medicina 2021;57(9):895. DOI: 10.3390/medicina57090895.
Shanbhag SS, Chodosh J, Fathy C. Goverman J, Mitchell C, Saeed HN. Multidisciplinary care in Stevens-Johnson syndrome. Ther Adv Chronic Dis. 2020;11:2040622319894469. DOI: 10.1177/2040622319894469.
Lerch M, Mainnetti C, Picolli BTB, Harr T. Current perspectives on Stevens-Johnson syndrome and toxic epidermal necrolysis. Clin Rev Allerg Immunol. 2018;54(1):147-76. DOI: 10.1007/s12016-017-8654-z.
Olteanu C, Shear NH, Chew HF, Hashimoto R, Alhusayen R, Whyte-Croasdaile S, et al. Severe physical complications among survivors of Stevens–Johnson syndrome and toxic epidermal necrolysis. Drug Saf. 2018;41(3):277-84. DOI: 10.1007/s40264-017-0608-0.
Gao X, Tang X, Ai L, Gao Q, Liao Q, Chen M, et al. Acute pancreatic injuries: A complication of Stevens-Johnson syndrome/toxic epidermal necrolysis. J Am Acad Dermatol. 2021 Mar;84(3):644-53. DOI: 10.1016/j.jaad.2020.06.043
Zhang AJ, Nygaard RM, Endorf FW, Hylwa SA. Stevens-Johnson syndrome and toxic epidermal necrolysis: Retrospective review of 10-year experience. Int J Dermatol. 2019;58(9):1069-77. DOI: 10.1111/ijd.14409.
Charlton OA, Harris V, Phan K, Mewton E, Jackson C, Cooper A. Toxic epidermal necrolysis and Steven–Johnson syndrome: A comprehensive review. Adv Wound Care. 2020 Jul;9(7):426-39. DOI: 10.1089/wound.2019.0977
Cheng L. Current pharmacogenetic perspective on Stevens-Johnson syndrome and toxic epidermal necrolysis. Front Pharmacol. 2021 Apr;12:588063. DOI: 10.3389/fphar.2021.588063
Alonso AE, Aramburu JA, Ruiz MRG, Cachafeiro L, Sanchez MS, Lorente Jose A. Review article: Toxic epidermal necrolysis: A paradigm of critical illness. Rev Bras Ter Intensiva. 2017 Oct-Dec;29(4):499-508. DOI: 10.5935/0103-507X.20170075.
Fakoya AOJ, Omenyi P, Anthony P, Anthony F, Etti P, Otohinoyi DA, et al. Stevens - Johnson syndrome and toxic epidermal necrolysis; Extensive review of reports of drug-induced etiologies, and possible therapeutic modalities. Open Access Maced J Med Sci. 2018;6(4):730-8. DOI: 10.3889/oamjms.2018.148.
Metcalfe D, Iqbal O, Chodosh J, Bouchard CS, Saeed HN. Acute and chronic management of ocular disease in Stevens Johnson syndrome/toxic epidermal necrolysis in the USA. Front Med. 2021;8:662897. DOI: 10.3389/fmed.2021.662897.
Lee HY, Walsh SA, Creamer D. Long-term complications of Stevens–Johnson syndrome/ toxic epidermal necrolysis (SJS/TEN): The spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multidisciplinary follow-up. Br J Dermatol. 2017 Oct;177(4):924-35. DOI: 10.1111/bjd.15360.
Bequignon E, Duong TA, Sbidian E, Valeyrie-Allanore L, Ingen-Housz-Oro S, Chatelin V, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis ear, nose, and throat description at acute stage and after remission. JAMA Dermatol. 2015;151(3):302-7. DOI:10.1001/jamadermatol.2014.4844.
Xu N, Chen X, Wu S, Ye M, Zhang M, Tong L, et al. Chronic pulmonary complications associated with toxic epidermal necrolysis: A case report and literature review. Exp Ther Med. 2018;3:2027-31. DOI: 10.3892/etm.2018.6357.
Kaneko Y , Kaneko Y, Seko Y, Sotozono C, Ueta M, Sato S, Shimamoto T, et al. Respiratory complications of Stevens-Johnson syndrome (SJS): 3 cases of SJS-induced obstructive bronchiolitis. Allergol Internat. 2020;69:465e467.
Canhao G, Pinheiro S, Cabral L. Toxic epidermal necrolysis: A clinical and therapeutic review. Eur Burn J. 2022;3:407–24.
Siddika A, Alassaf O, Rajani AR, Elberry MA. Could there be a relation between Steven-Johnson syndrome and ST-segment elevation myocardial infarction? BMJ Case Rep. 2019;12(11):e230331. DOI: 10.1136/bcr-2019-230331.
El-Azhary RA, Nowsheen S, Gibson LE, DiCaudo DJ. Disseminated intravascular coagulopathy: A complication of Stevens–Johnson syndrome/toxic epidermal necrolysis. Internat J Dermatol. 2021;2:185-9. DOI: 10.1111/ijd.15370.
Claytor JD, Herfarth HH, Weaver KN. Colonic involvement of Stevens-Johnson syndrome/toxic epidermal necrolysis: A rare cause of gastrointestinal bleeding. ACG Case Rep J. 2019;6:e00242. DOI:10.14309/crj.0000000000000242.
Lee TH, Lee CC, Ng CY, Chang MY, Chang SW, Fan PC, et al. The influence of acute kidney injury on the outcome of Stevens–Johnson syndrome and toxic epidermal necrolysis: The prognostic value of KDIGO staging. PLoS ONE 2018;13(9):e0203642.
Rattanakaemakorn P, Palakornkitti P, Pinyowiwat P, Jedee P, Thadanipon K. Chronic kidney disease is potentially an independent prognostic factor for death in Stevens-Johnson syndrome and toxic epidermal necrolysis patients. Front Med. 2022;9:939210. DOI: 10.3389/fmed.2022.939210.
Theva DP, Li L, Ng L. Urologic presentation of Stevens-Johnson syndrome: A case report. J Urol Ren Dis. 2017:JURD-130. DOI: 10.29011/2575-7903.000030.
Batavia JP, Chu DI, Long CJ, Canning DA, Weiss DA, Jen M. Genitourinary involvement and management in children with Stevens Johnson syndrome and toxic epidermal necrolysis. J Pediatr Urol. 2017(5):490.e1-490.e7. DOI: 10.1016/j.jpurol.2017.01.018.
Crowder CA, Jeney SES, Kraus CN, Bernal N, Lane F. Vulvovaginal involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis: management and techniques used to reduce gynecologic sequelae. Internat J Dermatol. 2022;61(2):158-63. DOI: 10.1111/ijd.15676.
Sharma AN, Hedayati B, Mesinkovska NA, Worswick S. Stevens-Johnson syndrome and toxic epidermal necrolysis in pregnant patients: A systematic review. Internat J Dermatol. 2022;6:239-47.
Magone MT, Maiberger M, Clayton J, Pasieka H. Vulvovaginal and ocular involvement and treatment in female patients with Stevens-Johnson syndrome and toxic epidermal necrolysis: A review. Int J Womens Dermatol. 2021;7(5Part A):520-8. DOI: 10.1016/j.ijwd.2021.08.012.
O’Reilly P, Meskell P, Whelan B, Kennedy C, Ramsay B, Coffey A, et al. Psychotherapeutic interventions for burns patients and the potential use with Stevens-Johnson syndrome and toxic epidermal necrolysis patients: A systematic integrative review. PLoS ONE 2022;17(6):e0270424.
O'Reilly P, Kennedy C, Meskell P, Coffey A, Delaunois I, Dore L, et al. The psychological impact of Stevens–Johnson syndrome and toxic epidermal necrolysis on patients’ lives: A critically appraised topic. Br J Dermatol. 2020;183:452–61. DOI: 10.1111/bjd.18746.
Lefaucheur JP, Valeyrie-Allanore L, Tin SNW, Abgrall G, Colin A, Hajj C, et al. Chronic pain: A long-term sequela of epidermal necrolysis (Stevens–Johnson syndrome/toxic epidermal necrolysis) – Prevalence, clinical characteristics and risk factors. J Eur Acad Dermatol Venereol. 2021;35(1):188-94. DOI: 10.1111/jdv.16891.
Hsu DY, Brieva J, Silverberg NB, Silverberg JI. Morbidity and mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis in United States adults. J Investig Dermatol. 2016;136:387e1397. DOI:10.1016/J.Jid.2016.03.023.
Hasegawa A, Abe R. Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis. F1000Res. 2020;9(F1000 Faculty Rev):61.
Unduhan
Diterbitkan
Cara Mengutip
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2024 Aribowo I Kadek
Artikel ini berlisensi Creative Commons Attribution-NonCommercial 4.0 International License.
